Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
The new Alzheimer’s drug Bapineuzumab has not lead to significant improvements. Bapineuzumab – an intravenous Alzheimer’s medication – recently went through a phase 3 trial in patients with mild-to-moderate Alzheimer’s disease whom did not carry the ApoE4 genotype (ApoE4 is thought to increase a person’s chance of developing Alzheimer’s and may worsen symptoms) announced Pfizer [...]
This week, the FDA filed a permanent injunction against two Minnesota companies that marketed and sold amino acid supplements as treatments for Parkinson’s, Alzheimer’s and other neurological disorders. To make matters worse, the companies also marketed their “amino-acid therapy” products as treatments for other problems, such as depression, attention-deficit hyperactivity disorder, fibromyalgia and obsessive compulsive [...]
